Expanding use of CD33-directed immunotherapy

Expert Opin Biol Ther. 2020 Sep;20(9):955-958. doi: 10.1080/14712598.2020.1788540. Epub 2020 Jul 2.

Author

Roland B Walter^{1

2

3

4}

Affiliations

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, WA, USA.
² Department of Medicine, Division of Hematology, University of Washington , Seattle, WA, USA.
³ Department of Pathology, University of Washington , Seattle, WA, USA.
⁴ Department of Epidemiology, University of Washington , Seattle, WA, USA.

PMID: 32580591
DOI: 10.1080/14712598.2020.1788540

No abstract available

Keywords: Acute myeloid leukemia (AML); CD33; drug target; immunotherapy; myeloid differentiation antigen.

Publication types

Editorial